医学
抗组胺药
不利影响
组胺H1受体
过敏反应
过敏
哮喘
药品
组胺
组胺H1拮抗剂
重症监护医学
药理学
免疫学
受体
内科学
敌手
作者
Giuseppe Fabio Parisi,Amelia Licari,Maria Papale,Sara Manti,Carmelo Salpietro,Salvatore Leonardi
摘要
Abstract Antihistamines are currently one of the most commonly administered drugs in children. They are used to treat symptoms that depend on histamine release, namely allergic diseases, such as rhinitis, asthma, urticaria, and anaphylaxis. It is possible to distinguish first‐ and second‐generation antihistamines. Pharmacological effects and therapeutic indications are similar, but second‐generation antihistamines have fewer adverse effects because they are more selective for peripheral H1 receptors. Although they have been on the market for several years, there are still many adverse effects linked to the antihistamine safety profile, especially in the first years of life. Thus, many antihistamines are prescribed off‐label, especially in children younger than 2 years of age, which is the age‐group where most of the data on drug safety are lacking and many antihistamines are not recommended. This article aims to provide a practical update on the use of antihistamines in children.
科研通智能强力驱动
Strongly Powered by AbleSci AI